AKT1 and breast cancer: Concerning the signalling molecules known to modulate proliferation/motility of breast tumor cells, no differences have been observed between CD133high and CD133low cells in the expression and activation levels of Akt, whose activity seems to have dichotomous effects on neoplastic progression of breast cancer [19].